Αρχική World News ASCO20 Virtual Research Round Up Podcast: Leukemia, Colorectal Cancer, and Lung Cancer

ASCO20 Virtual Research Round Up Podcast: Leukemia, Colorectal Cancer, and Lung Cancer

Every year, the ASCO Annual Meeting brings together attendees from around the globe to learn about the latest research in the treatment and care of people with cancer. Cancer.Net’s annual Research Round Up podcast series delves deep into the Annual Meeting’s scientific abstracts with leaders on this website’s Editorial Board. This year, a record 42,750 attendees from 138 countries worldwide gathered virtually for the ASCO20 Virtual Scientific Program, held May 29 through May 31.

In this year’s Research Round Up podcast series, Cancer.Net Associate Editors answer the question, “What was the most exciting or practice-changing research in your field presented at the ASCO20 Virtual Scientific Program?”

In the first episode for this year, 3 editors discuss new research in the fields of leukemia, colorectal cancer, and lung cancer. Listen below, and subscribe to Cancer.Net Podcasts on Apple Podcasts or Google Play for new episodes in this series throughout the summer.

Dr. Jessica Altman, the Cancer.Net Associate Editor for Leukemia, discusses an early study that looked at a combination of the immunotherapy magrolimab with the chemotherapy azacitidine (Vidaza) to treat myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). [3:05] She also discusses a study on the effects of supportive care, also known as palliative care, on quality of life for people treated for AML. [5:40]

Dr. Jeffrey Meyerhardt, the Cancer.Net Associate Editor for Genitourinary Cancers, discusses 4 studies on colorectal cancer. The first, KEYNOTE-177, looked at the effects of using an immunotherapy called pembrolizumab (Keytruda) to treat patients with metastatic colorectal cancer that had a specific genetic change, or mutation, known as microsatellite-instability high (MSI-H) or mismatch repair deficiency (dMMR). [8:50]

Next, he discusses an update to the BEACON CRC study, which looked at different combinations of targeted therapy to treat colorectal cancer with a genetic change known as a BRAF mutation. [11:13] Finally, he discusses 2 studies that looked at ways to improve adjuvant therapy for colorectal cancer. Adjuvant therapy is systemic therapy that is given after surgery. [13:09]

Dr. Jyoti Patel, the Cancer.Net Associate Editor for Lung Cancer, discusses 3 studies that explored different treatment options for non-small cell lung cancer (NSCLC). The first study she discusses, the ADAURA study, looked at the targeted therapy osimertinib (Tagrisso) to treat NSCLC with an EGFR mutation. [16:49] Next, she discusses the CheckMate 9LA study, which looked at a combination of 2 immunotherapy drugs, nivolumab (Opdivo) and ipilimumab (Yervoy), plus chemotherapy to treat metastatic or recurrent NSCLC. [20:26] Finally, she discusses a study that looked at the use of an antibody-drug conjugate, trastuzumab deruxtecan (Enhertu), to treat metastatic NSCLC with a HER2 mutation. [23:47]

Disclosure information for this podcast’s speakers can be found in their individual biographies, which are linked in the paragraphs above.

Was this podcast useful? Please subscribe, rate, and review Cancer.Net Podcasts on Apple Podcasts or Google Play. This prerecorded podcast can be listened to online or downloaded to your computer. A transcript is also available. For more information, visit the Cancer.Net podcast page.

Cancer.Net podcasts are edited for length and content.

Source

Προηγούμενο άρθροTables Turned
Επόμενο άρθροA tribute to Professor Anne Charlton

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer

On 13 October 2021, the US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with chemotherapy, with or without bevacizumab, for...

From Scan to Scan: The Challenges of Living with Metastatic Cancer

October 15, 2021, by NCI Staff Bethany Ross has been living with metastatic neuroendocrine cancer since she was diagnosed in 2018. Credit: Used with permission from...

The award-winning researcher behind next generation sequencing

Next generation sequencing (NGS) has given the genomic research community ultra-high throughput, scalability, and speed that could only be dreamed of 20 years ago....

Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t Tell Their Doctors

Cancer and cancer treatment come with many side effects, including nausea, vomiting, and pain. In addition to the physical toll, the impacts to a...

Medicare Open Enrollment Starts Tomorrow!

Medicare open enrollment is upon us for 2022. If you are a Medicare recipient, this is the time of year when you can make...

Cancer in My Community: Providing Supportive Care in Serbia

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with...